Advertisement

Cannabinoids and epilepsy — Introduction

Published:February 16, 2017DOI:https://doi.org/10.1016/j.yebeh.2017.01.015
      Over the past five years, the lay press and families of children with catastrophic epilepsies popularized the use of cannabis and cannabinoids to treat seizures [
      • Maa E.
      • Figi P.
      The case for medical marijuana in epilepsy.
      ]. Many state legislatures have responded to the pressure from lay groups and have legalized medical cannabis, which is now available to a majority of people in the United States. Patients throughout the world are also obtaining and using cannabinoids to treat their epilepsy. There is an enormous dissociation between the widespread use of cannabis-based therapies to treat diverse epilepsies and our understanding about the efficacy and safety of different cannabinoids in treating different epilepsy syndromes.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Epilepsy & Behavior
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Maa E.
        • Figi P.
        The case for medical marijuana in epilepsy.
        Epilepsia. 2014; 55: 783-786
        • Ware M.A.
        • Ziemianski D.
        Medical education on cannabis and cannabinoids: perspectives, challenges, and opportunities.
        Clin Pharmacol Ther. 2015; 97: 548-550